Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario

E-ISSN： 1873-4294|16|19|2189-2200

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.19, 2016-08, pp. : 2189-2200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing New Drugs for Diabetes and Cardiometabolic Disorders: A Changing Paradigm

By Krentz Andrew J. Morrow Linda Hompesch Marcus

Drugs, Vol. 72, Iss. 13, 2012-09 ,pp. : 1709-1711

Adis International

Access to resources Recommend Favorite

Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental Illness

Current Pharmaceutical Design, Vol. 21, Iss. 23, 2015-01 ,pp. : 3317-3324

Bentham Science Publishers

Access to resources Recommend Favorite

Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions

Current Drug Targets, Vol. 17, Iss. 2, 2016-02 ,pp. : 206-228

Bentham Science Publishers

Access to resources Recommend Favorite

Pigment Epithelium-derived Factor (PEDF) and Cardiometabolic Disorders

Current Pharmaceutical Design, Vol. 20, Iss. 14, 2014-04 ,pp. : 2377-2386

Bentham Science Publishers

Access to resources Recommend Favorite

An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 19, 2016-08 ,pp. : 2156-2168

Bentham Science Publishers

Access to resources Recommend Favorite